Cadence Re-Files FDA Application |  |
|
Posted by Mary Canady May 5th, 2010 .
| |
| No Comments |
Cadence Pharmaceuticals (NASDAQ: CADX), the San Diego-based developer of a pain reliever for use in hospitals, said today it has re-submitted its new drug application for the IV form of acetaminophen...
[[Click headline to continue reading.]]
[[Click headline to continue reading.]]
See other entries categorized in News, Syndication, Xconomy.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
